Life Sciences Archives - Page 3 of 20 - Becker's Hospital Review

Cancer drug pulled from US market | GLP-1s linked to lower addiction risk | FDA, states review plans to import drugs | Novo, Hims strike GLP-1 deal after legal feud | PE invests $1 trillion in healthcare in a decade

A new GLP-1 study, a cancer drug pulled from the US market and Novo strikes a deal with Hims. March 11, 2026 1. Cancer drug pulled from US market Full story 2. GLP-1 drugs tied to lower addiction risk: Study…

Cancer drug trial paused after death | Novo Nordisk inks $2B obesity drug deal | GLP-1s tied to higher osteoporosis risk | Intellia trial hold lifted | 12 drugs in shortage

Trial pause after patient death, a $2B obesity drug deal and new GLP-1 safety concerns. March 4, 2026 1. Novo Nordisk inks $2.1B oral obesity drug deal Full story 2. FDA partially pauses cancer drug trial after patient death Full…

Bayer sues J&J over cancer drug claims | Zepbound tops Novo Nordisk's GLP-1 in trial | FDA to drop 2-study rule | Schizophrenia, bipolar pill wins FDA OK | 6 healthcare notes from Trump's State of the Union

Drugmaker legal clash, GLP-1 data and FDA policy change. February 25, 2026 1. Bayer sues J&J over prostate cancer drug claims Full story 2. Trump's State of the Union: 6 healthcare takeaways Full story 3. 3,500 healthcare executives. 795 speakers.…

FDA reverses course on Moderna flu vaccine review | Biosimilar OK'd for chemo infection risk | Huntsman to manufacture 1st imaging drug in US | 5 notes on GLP-1s, cancer risk

FDA actions, GLP-1 data and a 1st-in-US drug manufacturing move. February 18, 2026 1. FDA reverses course; agrees to review Moderna flu vaccine Full story 2. Another win for GLP-1s and cancer risk: 5 study notes Full story 3. 2026…

War breaks out over GLP-1 pills | FDA refuses review of Moderna flu vaccine | Amgen won't withdraw rare disease drug | 4 drug candidates to watch

Regulatory setback for Moderna, Amgen stands firm, plus 4 pipeline drugs to watch. February 11, 2026 1. FDA refuses to review Moderna flu vaccine Full story 2. War breaks out over GLP-1 pills Full story 3. How will healthcare's new…

Breast cancer drug gets FDA priority review | FDA eyes boost to US drug manufacturing | Eli Lilly plans $3.5B injectable site | GLP-1s drive 79% pharma M&A surge | Penn State sues PBMs over pricing scheme

FDA actions, pharma investments and deals impacting life sciences. February 4, 2026 1. FDA grants priority review to breast cancer drug Full story 2. FDA delays approval of AstraZeneca's injectable lupus drug Full story 3. Margins, power brokers & site-of-care…

Texas AG probes vaccine incentives | Lilly inks $1.1B gene therapy deal | FDA lifts Intellia trial hold | Future GLP-1s may be gene therapies | Velsera names CEO

Gene therapy momentum builds: deals, trials and GLP-1s. January 28, 2026 1. Texas attorney general probes alleged immunization 'incentives': 4 vaccine updates Full story 2. Lilly inks $1.1B gene therapy deal for hearing loss Full story 3. 2026 strategy check:…

Eli Lilly, Novo Nordisk sued over GLP-1 access | FDA fast-tracks Parkinson’s cell therapy | 8 notes on bipartisan health package | FDA delays 2 priority drug reviews | Cedars-Sinai builds AI drug safety tool

FDA actions, GLP-1 access fight and an AI drug safety push. January 21, 2026 1. Compounding pharmacy sues Eli Lilly, Novo Nordisk over GLP-1 access Full story 2. FDA fast-tracks novel Parkinson's cell therapy Full story 3. Drug shortages are…

Eli Lilly, Nvidia to build $1B drug discovery lab | New drug trial guidelines proposed | FDA rejects cancer therapy | CDC vaccine changes spur uncertainty | Drug approvals to watch

Important updates to know in drug discovery and regulation. January 14, 2026 1. Lilly, Nvidia to launch $1B AI drug discovery lab Full story 2. FDA proposes new framework for clinical drug trial designs Full story 3. UAMS boosted nurse…

HHS overhauls pediatric vaccine schedule | FDA clears 1st oral GLP-1 | Eli Lilly sued over insulin pricing | FDA rejects cortisol modulator | 75 drugs in shortage

What to know on vaccines, GLP-1s and drug shortages January 7, 2026 1. HHS overhauls childhood vaccine recommendations: 4 things to know Full story 2. FDA approves Wegovy pill as 1st oral GLP-1 for weight loss Full story 3. Ardent…